Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

Completed · Phase 3 · Has a placebo group

Conditions studied: Glabellar Frown Lines (GL), Lateral Canthal Lines (LCL)

In brief

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Key facts

Study ID

NCT04247074

Run by

Galderma R&D

People needed

413

Starts

2020-02-10

Expected to finish

2021-02-26

Last updated by the study team

2023-09-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female 18 years of age or older.
• Moderate to severe LCL at maximum smile as assessed by the Investigator.
• Moderate to severe LCL at maximum smile as assessed by the subject.
• Moderate to severe GL at maximum frown as assessed by the Investigator.
• Moderate to severe GL at maximum frown as assessed by the subject

You may not qualify if…

• Previous use of any Botulinum toxin in facial areas within 9 months prior to study treatment.
• Female who is pregnant, breast feeding, or intends to conceive a child during the study.
• Known allergy or hypersensitivity to any component of the investigational product (QM1114-DP).

Where it is running

• Clinical Testing of Beverly Hills — Encino, California, United States
• Ava MD — Santa Monica, California, United States
• Skin Care & Laser Physicians of Beverly Hills — West Hollywood, California, United States
• Center for Clinical and Cosmetic Research — Aventura, Florida, United States
• Baumann Cosmetic & Research Institute, Inc — Miami, Florida, United States
• Washington Institute of Dermatologic Laser Surgery — Chevy Chase, Maryland, United States
• Maryland Dermatology, Laser, Skin & Vein Institute — Hunt Valley, Maryland, United States
• Skin Specialists, PC — Omaha, Nebraska, United States
• Lorenc Aesthetic Plastic Surgery Center — New York, New York, United States
• Elite Aesthetic Research — Cincinnati, Ohio, United States
• The Westlake Dermatology Clinical Research — Austin, Texas, United States
• Bertucci Medspa, Inc — Woodbridge, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.